(Q33904102)

29 July 2017

1 reference

title

Insulin-like growth factor binding proteins (IGFBPs) in breast cancer (English)

1 reference

29 July 2017

1 reference

Perks CM

1

1 reference

29 July 2017

Holly JM

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Journal of Mammary Gland Biology and Neoplasia

29 July 2017

published in

1 reference

29 July 2017

volume

5

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

75-84

1 reference

Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6

29 July 2017

cites work

1 reference

12 December 2020

The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor

1 reference

12 December 2020

Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients

1 reference

12 December 2020

IGF-independent regulation of breast cancer growth by IGF binding proteins

1 reference

12 December 2020

Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells

1 reference

12 December 2020

Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells

1 reference

12 December 2020

Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line

1 reference

12 December 2020

IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma

1 reference

12 December 2020

IGF binding protein-3 and the acid-labile subunit: formation of the ternary complex in vitro and in vivo

1 reference

12 December 2020

Insulin-like growth factor binding proteins in human breast cancer tissue

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 in breast cyst fluid: relationships with insulin-like growth factors I and II and transforming growth factor-beta 1 and 2

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival

1 reference

12 December 2020

Prostate-specific antigen (PSA) in women.

1 reference

12 December 2020

Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.

1 reference

12 December 2020

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

12 December 2020

Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells

1 reference

12 December 2020

Insulin-like growth factor binding proteins: a proposed superfamily

1 reference

12 December 2020

Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3

1 reference

12 December 2020

Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor

1 reference

12 December 2020

Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines.

1 reference

12 December 2020

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner

1 reference

12 December 2020

Insulin-like growth factor binding proteins.

1 reference

12 December 2020

Correlation of Insulin-Like Growth Factor-Binding Protein-3 Messenger RNA With Protein Expression in Primary Breast Cancer Tissues: Detection of Higher Levels in Tumors With Poor Prognostic Features

1 reference

12 December 2020

Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.

1 reference

12 December 2020

Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule

1 reference

12 December 2020

Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells

1 reference

12 December 2020

Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells.

1 reference

12 December 2020

Insulin-Like Growth Factor Binding Protein Secretion by Breast Carcinoma Cell Lines: Correlation with Estrogen Receptor Status*

1 reference

12 December 2020

Expression of IGF-I and IGF-II mRNA in breast tissue

1 reference

12 December 2020

Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells

1 reference

12 December 2020

Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients

1 reference

12 December 2020

Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid

1 reference

12 December 2020

A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin

1 reference

12 December 2020

Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II)

1 reference

12 December 2020

Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells

1 reference

12 December 2020

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

1 reference

12 December 2020

Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line

1 reference

12 December 2020

Induction of the growth inhibitor IGF-binding protein 3 by p53

1 reference

12 December 2020

Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast

1 reference

12 December 2020

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence

1 reference

12 December 2020

Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells

1 reference

12 December 2020

IGF binding proteins: regulation of cellular actions

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells

1 reference

12 December 2020

Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.

1 reference

12 December 2020

Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells

1 reference

12 December 2020

Tissue extraction procedures for investigation of urokinase plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in human breast carcinomas

1 reference

12 December 2020

Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation

1 reference

12 December 2020

Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218)

1 reference

12 December 2020

Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue

1 reference

12 December 2020

Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit

1 reference

12 December 2020

Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D.

1 reference

12 December 2020

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

1 reference

12 December 2020

Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk

1 reference

12 December 2020

Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells

1 reference

12 December 2020

Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition

1 reference

12 December 2020

Cathepsin D: a protease involved in breast cancer metastasis

1 reference

12 December 2020

Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I

1 reference

12 December 2020

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

12 December 2020

Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product

1 reference

12 December 2020

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

1 reference

12 December 2020

Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I

1 reference

12 December 2020

Insulin-like growth factors and their binding proteins: biological actions

1 reference

12 December 2020

Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells

1 reference

12 December 2020

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

1 reference

12 December 2020

Influence of treatment with onapristone on the IGF-system in breast cancer patients

1 reference

12 December 2020

Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation

1 reference

12 December 2020

Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.

1 reference

12 December 2020

Prostate specific antigen--new applications in breast and other cancers.

1 reference

12 December 2020

Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer

1 reference

12 December 2020

Regulation of Insulin-Like Growth Factor-Binding Protein (IGFBP) Expression by Breast Cancer Cells: Use of IGFBP-1 as as Inhibitor of Insulin-like Growth Factor Action

1 reference

12 December 2020

Tamoxifen reduces serum insulin-like growth factor I (IGF-I)

1 reference

12 December 2020

Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.

1 reference

12 December 2020

Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3

1 reference

12 December 2020

A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.

1 reference

12 December 2020

Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

1 reference

12 December 2020

Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media

1 reference

12 December 2020

Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients

1 reference

12 December 2020

Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.

1 reference

12 December 2020

Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

1 reference

12 December 2020

Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins

1 reference

12 December 2020

Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma

1 reference

12 December 2020

Anti-estrogen induced synthesis of transforming growth factor-beta in breast cancer patients

1 reference

12 December 2020

Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells

1 reference

12 December 2020

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

12 December 2020

Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues

1 reference

12 December 2020

Identification of insulin-like growth factor binding proteins in breast cancer cells

1 reference

12 December 2020

Clinical relevance of the urokinase plasminogen activator system in breast cancer

1 reference

12 December 2020

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1009519400591

1 reference

Dimensions Publication ID

29 July 2017

1047013311

0 references

1 reference